INNOVATIVE APPROACHES FOR CANCER TREATMENT
Wednesday, September 28th (15h00-16h30)
Moderator & Speaker:
- Sergio Ruiz Macías: Genomic Instability Group, CNIO - Spanish National Cancer Research Centre (Spain). ""Cas9/RNA-based forward genetic screenings to uncover the role of genes mediating resistance to chemotherapeutic agents"
- Juan Manuel Dominguez: Screening & Biochemistry Departamental Manager, PHARMAMAR (Spain). ""Novel cancer therapies inspired by the sea: Marine molecules conjugated to antibodies"
- Carles Domenech: CEO, ABILITY PHARMACEUTICALS (Spain). ""ABTL0812, a differentiated PI3K/Akt/mTOR inhibitor through TRIB3 overexpression in Phase 2 clinical trials"
- Laureano Simón: CEO, ONCOMATRYX BIOPHARMA (Spain). ""Targeting the tumor microenvironment to treat invasive cancer"